Skip to main content
SpringerLink
Log in

Pathogenesis of Graves’ Ophthalmopathy

  • Chapter
Graves’ Disease

Part of the book series: Endocrine Updates ((ENDO,volume 6))

  • 319 Accesses

Abstract

Graves’ disease is a relatively common disorder occurring primarily in women with an incidence of 1/1000 population/year (1). In addition to hyperthyroidism, 25–50% of individuals with Graves’ disease have clinical involvement of the eyes known as Graves’ ophthalmopathy (GO)(2). While some patients with GO experience only mild ocular discomfort, 3–5% of patients suffer from intense pain and inflammation with diplopia or even loss of vision. At present, GO is not preventable and therapeutic options for severe disease are limited. Recent insights into the pathogenesis of GO, reviewed here, have the potential to lead to new preventive and treatment strategies for this debilitating condition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vanderpump M, Turnbridge W, French J et al. 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 43:55–68.

    Article  CAS  Google Scholar 

  2. Bahn RS. 1995 Assessment and management of the patient with Graves’ ophthalmopathy. Endocr Pract. 1:172–178.

    PubMed  CAS  Google Scholar 

  3. Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM, Earnest F. 1986 Ophthalmopathy of Graves’ disease: computerized volume measurements of the orbital fat and muscle. AJNR. 7:651–656.

    PubMed  CAS  Google Scholar 

  4. Kahaly G, Forester G, Hansen C. 1998 Glycosaminoglycans in thyroid eye disease. Thyroid 8:429–432.

    Article  PubMed  CAS  Google Scholar 

  5. Bahn RS, Heufelder AE. 1993 Mechanisms of disease: Pathogenesis of Graves’ ophthalmopathy. N Engl J Med. 329:1468–1475.

    Article  PubMed  CAS  Google Scholar 

  6. Tallstedt L, Norberg R. 1988 Immunohistochemical staining of normal and Graves’ extraocular muscle. Invest Ophthalmol Vis Sci. 29:175–184.

    PubMed  CAS  Google Scholar 

  7. Rundle FF, Pochin EE. 1973 The orbital tissues in thyrotoxicosis: a quantitative analysis relating to exophthalmos. Clin Sci. 5:51–74.

    Google Scholar 

  8. Peyster RG, Ginsberg F, Silber JH, Adler LP. 1986 Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis. AJNR. 7:35–40.

    Google Scholar 

  9. Heufelder AE, Bahn RS. 1993 Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves’ ophthalmopathy. Eur J Clin Invest. 23: 10–17.

    Article  PubMed  CAS  Google Scholar 

  10. Weetman AP. 1991 Thyroid-associated eye disease: pathophysiology. Lancet 338:25–28.

    Article  PubMed  CAS  Google Scholar 

  11. DeCarli M, D’Elios MM, Mariotti S, et al. 1993 Cytolytic T cells with Th-1-like cytokine profile predominate in retroorbital lymphocytic infiltrates in Graves’ ophthalmopathy. J Clin Endocrinol Metab. 77:1120–1124.

    Article  CAS  Google Scholar 

  12. Yang D, Hiromatsu Y, Hoshino T, Inoue Y, Itoh K, Nonaka K. 1999 Dominant infiltration of TH 1 -type CD4+ cells at the retrobulbar space of patients with thyroid-associated ophthalmopathy. Thyroid 9:305–310.

    Article  PubMed  CAS  Google Scholar 

  13. McLachlan SM, Prummel MF, Rapoport B. 1994 Cell-mediated or humoral immunity in Graves’ ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. J Clin Endocrinol Metab. 78:1070–1074.

    Article  PubMed  CAS  Google Scholar 

  14. Grubeck-Loebenstein B, Trieb K, Sztankay A, Holter W, Anderl H, Wick G. 1994 Retrobulbar T cells from patients with Graves’ ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. J Clin Invest. 93:2738–2743.

    Article  PubMed  CAS  Google Scholar 

  15. Natt N, Bahn RS. 1997 Cytokines in the evolution of Graves’ ophthalmopathy. Autoimmunity 26:129–136.

    Article  PubMed  CAS  Google Scholar 

  16. Dinarello CA. 1991 Inflammatory cytokines: Interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases. Curr Opin Immunol. 4:941–951.

    Article  Google Scholar 

  17. Smith TJ, Wang HS, Evans CH. 1995 Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts. Am J Physiol. 268:C382–C388.

    PubMed  CAS  Google Scholar 

  18. Heufelder AE, Bahn RS. 1994 Modulation of orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists. Invest Ophthalmol Vis Sci. 35:120–127.

    PubMed  CAS  Google Scholar 

  19. Wang HS, Cao HJ, Winn VD, et al. 1996 Leukoregulin induction of prostaglandin-endoperoxide H synthase-2 in human orbital fibroblasts. An in vitro model for connective tissue inflammation. J Biol Chem. 271:22718–22728.

    Article  PubMed  CAS  Google Scholar 

  20. Young DA, Evans CH, Smith TJ. 1998 Leukoregulin induction of protein expression in human orbital fibroblasts: evidence for anatomical site-restricted cytokine-target cell interactions. Proc Natl Acad Sci USA. 95:8904–8909.

    Article  PubMed  CAS  Google Scholar 

  21. Reddy L, Wang HS, Keese CR, Giaever I, Smith TJ. 1998 Assessment of rapid morphological changes associated with elevated cAMP levels in human orbital fibroblasts. Exp Cell Res. 245:360–367.

    Article  PubMed  CAS  Google Scholar 

  22. Heufelder AE, Dutton CM, Sarkar G, Donovan KA, Bahn RS. 1993 Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves’ ophthalmopathy and pretibial dermopathy. Thyroid 3:297–300.

    Article  PubMed  CAS  Google Scholar 

  23. Feliciello A, Porcellini A, Ciullo, Bonavolonta G, Avvedimento EV, Fenzi G. 1993 Expression of thyrotropin-receptor mRNA in healthy and Graves’ retro-orbital tissue. Lancet 342:337–338.

    Article  PubMed  CAS  Google Scholar 

  24. Mengistu M, Lukes YG, Nagy EV, Burch HB, Carr FE, Lahiri S, Burman KD. 1994 TSH receptor expression in retroocular fibroblasts. J Endocrinol Invest. 17:437–441.

    PubMed  CAS  Google Scholar 

  25. Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE. 1998 Thyrotropin receptor expression in Graves’ orbital adipose/connective tissues: Potential autoantigen in Graves’ ophthalmopathy. J Clin Endocrinol Metab. 83:998–1002.

    Article  PubMed  CAS  Google Scholar 

  26. Förster G, Otto E, Hansen C, Ochs K, Kahaly G. 1998 Analysis of orbital T cells in thyroid-associated ophthalmopathy. Clin Exp Immunol. 112:427–434.

    Article  PubMed  Google Scholar 

  27. Costagliola S, Rodien P, Many MC, Ludgate M, Vassart G. 1998 Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol. 160:1458–1465.

    PubMed  CAS  Google Scholar 

  28. Many MC, Costagliola S, Detrout M, Denef F, Vassart G, Ludgate MC. 1999 Development of an animal model of autoimmune thyroid eye disease. J Immunol. 162:4966–4974.

    PubMed  CAS  Google Scholar 

  29. Rodbell M. 1964 Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem. 239:375–380.

    PubMed  CAS  Google Scholar 

  30. Davies TF, Teng CS, McLachlan SM, Smith BR, Hall R. 1978 Thyrotropin receptors in adipose tissue, retro-orbital tissue and lymphocytes. Mol Cell Endocrinol. 9:303–310.

    Article  PubMed  CAS  Google Scholar 

  31. Perros P, Kendall-Taylor P. 1994 Demon tration of thyrotropin binding sites in orbital connective tissue: Possible role in the pathog nesis of thyroid-associated ophthalmopathy. J Endocrinol Invest. 17:163–170.

    PubMed  CAS  Google Scholar 

  32. Kendall-Taylor P, Munro DS. 1971 The lipolytic activity of long-acting thyroid stimulator. Biochem Biophys Acta. 231:314–319.

    Article  PubMed  CAS  Google Scholar 

  33. Iida Y, Amir, S, Ingbar SH. 1987 Stabilization, partial purification, and characterization of thyrotropin receptors in solubilized guinea pig fat cell membranes. Endocrinology 121:1627–1636.

    Article  PubMed  CAS  Google Scholar 

  34. Roselli-Rehfuss L, Robbins LS, Cone RD. 1992 Thyrotropin receptor messenger ribonucleic acid is expressed in most brown and white adipose tissues in the guinea pig. Endocrinology 130:1857–1861.

    Article  PubMed  CAS  Google Scholar 

  35. Haraguchi K, Shimura H, Ling Lin, Saito T, Endo T, Onaya T. 1996 Differentiation of rat preadipocytes is accompanied by expression of thyrotropin receptors. Endocrinology 137: 3200–3205.

    Article  PubMed  Google Scholar 

  36. Mullin BR, Lee G, Ledley FD, Winand RJ, Kohn LD. 1976 Thyrotropin interactions with human fat cell membrane preparations and the finding of a soluble thyrotropin binding component. Biochem Biophys Res Comm. 69:55–62.

    Article  PubMed  CAS  Google Scholar 

  37. Marcus C, Ehren H, Bolme P, Arner P. 1988 Regulation of lipolysis during the neonatal period: Importance of thyrotropin. J Clin Invest. 82:1793–1797.

    Article  PubMed  CAS  Google Scholar 

  38. Janson A, Karlsson FA, Micha-Johansson G, Bolme P, Bronnegard M, Marcus C. 1995 Effects of stimulatory and inhibitory thyrotropin receptor antibodies on lipolysis in infant adipocytes. J Clin Endocrinol Metab. 80:1712–1716.

    Article  PubMed  CAS  Google Scholar 

  39. Poznanski W, Waheed I, Van R. 1973 Human fat cell precursors. Morphologic and metabolic differentiation in culture. J Lab Invest. 29: 570–576.

    CAS  Google Scholar 

  40. Smas CM, Sul HS. 1995 Control of adipocyte differentiation. Biochem. 309:697–710.

    CAS  Google Scholar 

  41. Sorisky A, Pardasani D, Gagnon A, Smith TJ. 1996 Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J Clin Endocrinol Metab. 81:3428–3431.

    Article  PubMed  CAS  Google Scholar 

  42. Valyasevi RW, Erickson DZ, Harteneck DA, et al. 1999 Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab. 84:2557–2562.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Rebecca S. Bahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Autoimmune Disease Unit, Cedars-Sinai Research Institute and U.C.L.A. School of Medicine, Los Angeles, California, USA

    Basil Rapoport M.B., Ch.B.  & Sandra M. McLachlan Ph.D  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bahn, R.S. (2000). Pathogenesis of Graves’ Ophthalmopathy. In: Rapoport, B., McLachlan, S.M. (eds) Graves’ Disease. Endocrine Updates, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4407-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4407-4_18

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6983-7

  • Online ISBN: 978-1-4615-4407-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation